Upsher-Smith Laboratories, LLC is a trusted U.S. pharmaceutical company that has strived to deliver quality, affordable generic medications for nearly a century. In June 2017, Upsher-Smith was acquired by Sawai Pharmaceutical Co., Ltd., a large publicly traded generics company in Japan that had been seeking entry into the U.S. market. Upsher-Smith and Sawai share a strikingly similar family history and hold many of the same cherished goals and values—most importantly, the philosophy of always putting patients first.

Upsher-Smith will continue to do those things we feel we do best—provide a consistent supply of quality, affordable medications, and invest in our historically strong industry relationships. And as we further organize into one global company with Sawai, we will begin to benefit from Sawai’s extensive resources and management focus. Ultimately, we believe our acquisition by Sawai represents a tremendous opportunity to leverage each other for growth worldwide as we embark together on an exciting new chapter in generics.